Who actually qualifies for a GLP-1 prescription

GLP-1 medications are everywhere in advertising, which can leave the impression that anyone who wants one can simply ask. The clinical reality is narrower and more specific. There are defined criteria for who these drugs are approved to treat, separate questions about who should avoid them, and a third issue entirely of who can get them paid for. It helps to keep those three things apart.

The weight-based criteria

For weight management, the approved thresholds are built around body mass index. In general, the medications are indicated for adults with a BMI of 30 or higher, which is the standard cutoff for obesity, or a BMI of 27 or higher when there is at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. The FDA approval of semaglutide for chronic weight management spells out this BMI framework, and you can estimate your own number with the BMI tool from the National Heart, Lung, and Blood Institute. BMI is an imperfect measure and a clinician will read it alongside your overall picture, but it remains the entry point for eligibility.

Diabetes is a separate lane

Some of these drugs are approved primarily to treat type 2 diabetes rather than weight, even though weight loss is a common effect. The National Institute of Diabetes and Digestive and Kidney Diseases notes that several prescription medications work on appetite and metabolism, and the specific brand and indication determine the path. This is why the same active ingredient can appear under one name for diabetes and another for weight. It matters for both prescribing and coverage.

Who should be cautious or avoid them

Qualifying by BMI is not the end of the conversation. These medications are generally not recommended for people with a personal or family history of medullary thyroid cancer or a syndrome called multiple endocrine neoplasia type 2, and a history of pancreatitis calls for careful discussion. They are not used during pregnancy or while trying to conceive, and they are not intended for people without a weight or metabolic indication who simply want to lose a few pounds. A clinician screens for all of this, which is one reason a real medical evaluation matters and this article is general information rather than personal advice.

Qualifying is not the same as coverage

Here is the gap that surprises people most. You can meet every clinical criterion and still find your insurance will not pay. Many plans cover these drugs for diabetes but not for weight, require documentation that you tried other approaches first, or exclude them outright. So there are effectively two questions: am I a medical candidate, and can I get this paid for, and the answers are often different. We walk through that maze in GLP-1 insurance and cost, which is essential reading before you assume a prescription means an affordable prescription.

How people actually get evaluated

Eligibility is assessed by a licensed clinician, whether in a doctor's office or through a reputable telehealth service. A serious evaluation reviews your weight history, related conditions, current medications, and risk factors, not just a BMI number entered on a form. Be wary of any service that hands out prescriptions with almost no review, because the screening exists to protect you. If you are weighing the two routes, our comparison of telehealth versus in-person GLP-1 care lays out the tradeoffs.

The takeaway

The honest summary is that GLP-1 medications are approved for adults with obesity, or with excess weight plus a related health condition, and separately for type 2 diabetes, and that meeting the criteria still leaves the coverage question wide open. Find out where you stand on both fronts before you get attached to a plan. Start with a real clinical evaluation, ask directly whether you are a candidate, and then turn to the cost question. For that second half, read GLP-1 insurance and cost.

Related reading: Telehealth versus in-person GLP-1 care.